MedTrace Logo

Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches & Across INcarceration Settings

NCT07563517 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2026-05-04

No results posted yet for this study

Summary

The goal of this study is to learn whether a virtual peer recovery coach (PRC) intervention can improve engagement in addiction treatment among incarcerated adults with substance use disorders.

The main questions it aims to answer are:

* Does the PRC intervention increase engagement with at least one recovery resource at 30 and 90 days?
* Does it improve secondary outcomes such as substance use, recovery capital, overdose events, and recidivism?

Researchers will compare Treatment-as-Usual with the PRC telehealth intervention to see if PRC support improves engagement in addiction care.

Participants will:

* Complete baseline and follow-up assessments
* Receive either Treatment-as-Usual or a virtual PRC session focused on motivational interviewing and linkage to recovery resources

Conditions

  • Substance Use

Interventions

BEHAVIORAL

Virtual Peer Recovery Coaching

A telehealth session with a peer recovery coach who provides motivational interviewing and tailored linkage to addiction treatment and recovery resources.

BEHAVIORAL

Treatment as Usual

Participants are provided information about community-based addiction treatment and recovery resources as part of routine jail processes.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Joseph Carpenter, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2030-03-31
Completion
2030-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07563517 on ClinicalTrials.gov